![These highlights do not include all the information needed to use NORDITROPIN safely and effectively. See full prescribing information for NORDITROPIN. NORDITROPIN ® (somatropin) injection, for subcutaneous useInitial U.S. Approval: 1987 These highlights do not include all the information needed to use NORDITROPIN safely and effectively. See full prescribing information for NORDITROPIN. NORDITROPIN ® (somatropin) injection, for subcutaneous useInitial U.S. Approval: 1987](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-44.jpg&id=669792)
These highlights do not include all the information needed to use NORDITROPIN safely and effectively. See full prescribing information for NORDITROPIN. NORDITROPIN ® (somatropin) injection, for subcutaneous useInitial U.S. Approval: 1987
Novo Nordisk A/S: Once-weekly Sogroya® (somapacitan) receives CHMP positive opinion for expanded use in children and adolescents with growth hormone deficiency
![These highlights do not include all the information needed to use NORDITROPIN safely and effectively. See full prescribing information for NORDITROPIN. NORDITROPIN ® (somatropin) injection, for subcutaneous useInitial U.S. Approval: 1987 These highlights do not include all the information needed to use NORDITROPIN safely and effectively. See full prescribing information for NORDITROPIN. NORDITROPIN ® (somatropin) injection, for subcutaneous useInitial U.S. Approval: 1987](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-101.jpg&id=669792)